SE421421B - Analogiforfarande for framstellning av antiarytmiska medel - Google Patents

Analogiforfarande for framstellning av antiarytmiska medel

Info

Publication number
SE421421B
SE421421B SE7510362A SE7510362A SE421421B SE 421421 B SE421421 B SE 421421B SE 7510362 A SE7510362 A SE 7510362A SE 7510362 A SE7510362 A SE 7510362A SE 421421 B SE421421 B SE 421421B
Authority
SE
Sweden
Prior art keywords
antiarithmic
agents
preparation
analogy procedure
analogy
Prior art date
Application number
SE7510362A
Other languages
English (en)
Swedish (sv)
Other versions
SE7510362L (sv
Inventor
R L Buchanan
A M Jelenevsky
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE7510362L publication Critical patent/SE7510362L/xx
Publication of SE421421B publication Critical patent/SE421421B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
SE7510362A 1974-09-18 1975-09-16 Analogiforfarande for framstellning av antiarytmiska medel SE421421B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50702974A 1974-09-18 1974-09-18
US05/594,918 US3980668A (en) 1974-09-18 1975-07-10 Anti-arrhythimic 5-endo-(3-indolecarbonyloxy)-N-[amino-(lower)alkyl]bicyclo[2,2,1]heptane-2,3-di-endo-carboxylic acid imides

Publications (2)

Publication Number Publication Date
SE7510362L SE7510362L (sv) 1976-03-19
SE421421B true SE421421B (sv) 1981-12-21

Family

ID=27055675

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7510362A SE421421B (sv) 1974-09-18 1975-09-16 Analogiforfarande for framstellning av antiarytmiska medel

Country Status (24)

Country Link
US (1) US3980668A (no)
JP (1) JPS6039669B2 (no)
AR (1) AR212235A1 (no)
AT (1) AT345275B (no)
CA (1) CA1068281A (no)
CH (1) CH615925A5 (no)
CS (1) CS187489B2 (no)
DD (1) DD123092A5 (no)
DE (1) DE2541434A1 (no)
DK (1) DK418075A (no)
ES (2) ES441038A1 (no)
FI (1) FI64352C (no)
FR (1) FR2313047A1 (no)
GB (1) GB1484214A (no)
HU (1) HU173807B (no)
IE (1) IE42051B1 (no)
IL (1) IL48096A (no)
LU (1) LU73418A1 (no)
NL (1) NL7510934A (no)
NO (1) NO144072C (no)
PH (1) PH11498A (no)
PL (2) PL101454B1 (no)
SE (1) SE421421B (no)
YU (2) YU40123B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557341A1 (de) * 1975-12-19 1977-06-30 Hoechst Ag Basisch substituierte indolderivate und verfahren zu ihrer herstellung
US4139533A (en) * 1976-08-19 1979-02-13 Bristol-Myers Company Bicyclo[2,2,1]heptane-2,3-diendo carboxylic acid imide esters of quinoline carboxylic acid
GB8814277D0 (en) * 1988-06-16 1988-07-20 Glaxo Group Ltd Chemical compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3850921A (en) * 1972-09-20 1974-11-26 I Matuo Derivatives of 2,3-norbornanedicarboxamide

Also Published As

Publication number Publication date
YU40123B (en) 1985-08-31
YU284082A (en) 1985-04-30
IL48096A (en) 1979-09-30
NO144072B (no) 1981-03-09
ES441038A1 (es) 1977-07-01
LU73418A1 (no) 1976-08-13
PL101454B1 (pl) 1978-12-30
NL7510934A (nl) 1976-03-22
SE7510362L (sv) 1976-03-19
IL48096A0 (en) 1975-11-25
AR212235A1 (es) 1978-06-15
CH615925A5 (no) 1980-02-29
ES455938A1 (es) 1978-02-01
IE42051B1 (en) 1980-05-21
GB1484214A (en) 1977-09-01
CS187489B2 (en) 1979-01-31
HU173807B (no) 1979-08-28
DD123092A5 (no) 1976-11-20
US3980668A (en) 1976-09-14
ATA718575A (de) 1978-01-15
FI752572A (no) 1976-03-19
NO144072C (no) 1981-06-17
CA1068281A (en) 1979-12-18
PH11498A (en) 1978-02-01
NO753128L (no) 1976-03-19
DK418075A (da) 1976-03-19
FR2313047B1 (no) 1979-09-14
FI64352C (fi) 1983-11-10
IE42051L (en) 1976-03-18
JPS51131871A (en) 1976-11-16
YU225375A (en) 1983-12-31
AU8459775A (en) 1977-03-10
DE2541434A1 (de) 1976-04-08
AT345275B (de) 1978-09-11
JPS6039669B2 (ja) 1985-09-06
FR2313047A1 (fr) 1976-12-31
FI64352B (fi) 1983-07-29
PL100522B1 (pl) 1978-10-31

Similar Documents

Publication Publication Date Title
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
NO145075C (no) Kontinuerlig fremgangsmaate til fremstilling av alkoksysilaner
NO142196C (no) Fremgangsmaate for fremstilling av avfarvede kaldtvannsopploeselige tegarvestoffer
SE7513085L (sv) Forfarande for framstellning av etrar
SE412401B (sv) Forfarande for framstellning av polyvinylpyrroliden-jod
SE7810002L (sv) Forfarande for framstellning av fenylalkylaminer
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE431207B (sv) Forfarande for framstellning av tiazolidinderivat
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE421421B (sv) Analogiforfarande for framstellning av antiarytmiska medel
SE431547B (sv) Forfarande for framstellning av 3-metylencefamsulfoxider
SE420097B (sv) Forfarande for framstellning av hydroxialkylxantiner
SE423815B (sv) Forfarande for framstellning av aminometylarylmetylpenicilliner
SE422679B (sv) Forfarande for framstellning av etynylbensenforeningar
SE424548B (sv) Forfarande for framstellning av alkylsulfonylfenoxipropanolaminer
NO149427C (no) Fremgangsmaate for fremstilling av fenyl- henholdsvis naftyl-uretaner.